Gilead Sciences Inc (GILD)
92.57
+1.48
(+1.62%)
USD |
NASDAQ |
Dec 20, 16:00
92.57
0.00 (0.00%)
After-Hours: 20:00
Gilead Sciences Shareholders Equity (Quarterly): 18.47B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 92.29B |
| Eli Lilly and Co | 14.24B |
| Merck & Co Inc | 44.50B |
| AbbVie Inc | 6.032B |
| Amgen Inc | 7.527B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 54.52B |
| Total Liabilities (Quarterly) | 36.14B |
| Debt to Equity Ratio | 1.258 |
| Current Ratio | 1.261 |
| Net Debt Paydown Yield | 0.38% |